ABBV vs GSK: Which Is the Better Dividend Stock?
As of Nov 6, 2026, ABBV (AbbVie Inc.) screens as the stronger dividend stock, winning 5 of 8 head-to-head metrics. GSK offers the higher yield at 3.60%, ABBV has the higher dividend-safety score, and GSK looks like the better value (its fair-value estimate is 11% below its share price).
Key facts: ABBV vs GSK
Data as of · Source: SmarterDividends data
- As of Nov 6, 2026, GSK plc (GSK) has the higher forward dividend yield at 3.60%, versus 2.40% for AbbVie Inc. (ABBV).
- As of Nov 6, 2026, SmarterDividends grades ABBV's dividend safety A (80/100) and GSK's C (60/100).
- By SmarterDividends' count as of Nov 6, 2026, ABBV has raised its dividend for 12 consecutive years and GSK for 2.
- As of Nov 6, 2026, ABBV pays out 117% of its earnings as dividends and GSK pays out 63%.
- As of Nov 6, 2026, ABBV's fair-value estimate is 33% below its share price and GSK's fair-value estimate is 11% below its share price, so GSK looks like the better value of the two on SmarterDividends' blended model.
Cite this page
SmarterDividends, "ABBV vs GSK: Dividend Yield, Safety & Value Compared," updated Nov 6, 2026, https://smarterdividends.com/compare/abbv-vs-gsk
| Metric | ABBV | GSK |
|---|---|---|
| Forward yield | 2.40% | 3.60% |
| Annual dividend | $6.92 | $1.82 |
| Payout ratio | 117% | 63% |
| Years of growth | 12 yr | 2 yr |
| 5-yr dividend growth | 6.8% | -4.0% |
| 5-yr total return | 156% | 20% |
| Dividend safety score | 80 (A) | 60 (C) |
| Fair value estimate | $192.09 | $44.63 |
| Upside to fair value | -33% | -11% |
| Frequency | quarterly | quarterly |
| Market cap | $509.5B | $101.0B |
| P/E ratio | 50.7 | 17.6 |
Higher yield
GSK
3.60%
Safer dividend
ABBV
Grade A
Faster growth
ABBV
6.8%
Better value
GSK
-11% upside
ABBV vs GSK — FAQ
Is ABBV or GSK a better dividend stock?
On the data, ABBV wins more head-to-head categories (5 vs 3). GSK offers the higher yield (3.60%), while ABBV has the stronger dividend-safety score. The right pick depends on whether you prioritise income, safety or value.
Which has a higher dividend yield, ABBV or GSK?
GSK has the higher forward dividend yield at 3.60%, versus 2.40% for ABBV.
Is ABBV or GSK safer?
ABBV has the higher dividend-safety score (80/100 vs 60/100), reflecting stronger payout coverage and dividend-growth history.
Is ABBV or GSK better value right now?
As of Nov 6, 2026, GSK looks like the better value: its fair-value estimate is 11% below its share price (fairly valued). For ABBV, its fair-value estimate is 33% below its share price.
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.